{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T02:52:17Z","timestamp":1794883937221,"version":"4.9.1"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T00:00:00Z","timestamp":1701734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T00:00:00Z","timestamp":1701734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Biomed. Eng"],"DOI":"10.1038\/s41551-023-01145-8","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T06:02:08Z","timestamp":1701756128000},"page":"1266-1284","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Inflammation-induced subcutaneous neovascularization for the long-term survival of encapsulated islets without immunosuppression"],"prefix":"10.1038","volume":"8","author":[{"given":"Long-Hai","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7224-2127","authenticated-orcid":false,"given":"Braulio A.","family":"Marfil-Garza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6209-8486","authenticated-orcid":false,"given":"Alexander U.","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rena L.","family":"Pawlick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2227-4446","authenticated-orcid":false,"given":"Andrew R.","family":"Pepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4658-6871","authenticated-orcid":false,"given":"Kento","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Epel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navin","family":"Viswakarma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrignayani","family":"Kotecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Arthur","family":"Flanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1397-6892","authenticated-orcid":false,"given":"Ashim K.","family":"Datta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Jie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0319-4165","authenticated-orcid":false,"given":"Ye-Zi","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9553-7526","authenticated-orcid":false,"given":"Minglin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6215-0990","authenticated-orcid":false,"given":"A. M. James","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,5]]},"reference":[{"key":"1145_CR1","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1016\/S0140-6736(18)31320-5","volume":"391","author":"LA DiMeglio","year":"2018","unstructured":"DiMeglio, L. A., Evans-Molina, C. & Oram, R. A. Type 1 diabetes. Lancet 391, 2449\u20132462 (2018).","journal-title":"Lancet"},{"key":"1145_CR2","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.2337\/db14-0059","volume":"63","author":"PE Cryer","year":"2014","unstructured":"Cryer, P. E. Glycemic goals in diabetes: trade-off between glycemic control and iatrogenic hypoglycemia. Diabetes 63, 2188\u20132195 (2014).","journal-title":"Diabetes"},{"key":"1145_CR3","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.2337\/dc15-0090","volume":"38","author":"P Choudhary","year":"2015","unstructured":"Choudhary, P. et al. Evidence-informed clinical practice recommendations for treatment of type 1 diabetes complicated by problematic hypoglycemia. Diabetes Care 38, 1016\u20131029 (2015).","journal-title":"Diabetes Care"},{"key":"1145_CR4","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S2213-8587(22)00114-0","volume":"10","author":"BA Marfil-Garza","year":"2022","unstructured":"Marfil-Garza, B. A. et al. Pancreatic islet transplantation in type 1 diabetes: 20-year experience from a single-centre cohort in Canada. Lancet Diabetes Endocrinol. 10, 519\u2013532 (2022).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1145_CR5","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.2337\/dc20-2458","volume":"44","author":"JRN Lemos","year":"2021","unstructured":"Lemos, J. R. N. et al. Survival after islet transplantation in subjects with type 1 diabetes: twenty-year follow-up. Diabetes Care 44, e67\u2013e68 (2021).","journal-title":"Diabetes Care"},{"key":"1145_CR6","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.1111\/ajt.16637","volume":"21","author":"S Lablanche","year":"2021","unstructured":"Lablanche, S. et al. Ten\u2010year outcomes of islet transplantation in patients with type 1 diabetes: data from the Swiss\u2013French GRAGIL network. Am. J. Transplant. 21, 3725\u20133733 (2021).","journal-title":"Am. J. Transplant."},{"key":"1145_CR7","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.2337\/dc19-0401","volume":"42","author":"M-C Vantyghem","year":"2019","unstructured":"Vantyghem, M.-C. et al. Ten-year outcome of islet alone or islet after kidney transplantation in type 1 diabetes: a prospective parallel-arm cohort study. Diabetes Care 42, 2042\u20132049 (2019).","journal-title":"Diabetes Care"},{"key":"1145_CR8","doi-asserted-by":"publisher","first-page":"e973","DOI":"10.1210\/clinem\/dgab787","volume":"107","author":"JRN Lemos","year":"2022","unstructured":"Lemos, J. R. N. et al. Prolonged islet allograft function is associated with female sex in patients after islet transplantation. J. Clin. Endocrinol. Metab. 107, e973\u2013e979 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1145_CR9","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nrd.2016.232","volume":"16","author":"T Desai","year":"2017","unstructured":"Desai, T. & Shea, L. D. Advances in islet encapsulation technologies. Nat. Rev. Drug Discov. 16, 338\u2013350 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1145_CR10","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.addr.2018.04.018","volume":"139","author":"M Farina","year":"2019","unstructured":"Farina, M. et al. Cell encapsulation: overcoming barriers in cell transplantation in diabetes and beyond. Adv. Drug Deliv. Rev. 139, 92\u2013115 (2019).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"1145_CR11","doi-asserted-by":"publisher","first-page":"11458","DOI":"10.1021\/acs.chemrev.0c01062","volume":"121","author":"S Fuchs","year":"2020","unstructured":"Fuchs, S. et al. Hydrogels in emerging technologies for type 1 diabetes. Chem. Rev. 121, 11458\u201311526 (2020).","journal-title":"Chem. Rev."},{"key":"1145_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.addr.2013.07.018","volume":"67","author":"DW Scharp","year":"2014","unstructured":"Scharp, D. W. & Marchetti, P. Encapsulated islets for diabetes therapy: history, current progress, and critical issues requiring solution. Adv. Drug Deliv. Rev. 67, 35\u201373 (2014).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"1145_CR13","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.tibtech.2018.01.007","volume":"36","author":"G Orive","year":"2018","unstructured":"Orive, G. et al. Engineering a clinically translatable bioartificial pancreas to treat type I diabetes. Trends Biotechnol. 36, 445\u2013456 (2018).","journal-title":"Trends Biotechnol."},{"key":"1145_CR14","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1002\/cphy.c190033","volume":"10","author":"BA Marfil\u2010Garza","year":"2020","unstructured":"Marfil\u2010Garza, B. A., Polishevska, K., Pepper, A. R. & Korbutt, G. S. Current state and evidence of cellular encapsulation strategies in type 1 diabetes. Compr. Physiol. 10, 839\u2013878 (2020).","journal-title":"Compr. Physiol."},{"key":"1145_CR15","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/j.stem.2021.10.003","volume":"28","author":"A Ramzy","year":"2021","unstructured":"Ramzy, A. et al. Implanted pluripotent stem-cell-derived pancreatic endoderm cells secrete glucose-responsive C-peptide in patients with type 1 diabetes. Cell Stem Cell 28, 2047\u20132061.e45 (2021).","journal-title":"Cell Stem Cell"},{"key":"1145_CR16","doi-asserted-by":"crossref","unstructured":"Shapiro, A. M. J. et al. Insulin expression and C-peptide in type 1 diabetes subjects implanted with stem cell-derived pancreatic endoderm cells in an encapsulation device. Cell. Rep. Med. 2, 100466 (2021).","DOI":"10.1016\/j.xcrm.2021.100466"},{"key":"1145_CR17","doi-asserted-by":"publisher","first-page":"2100820","DOI":"10.1002\/advs.202100820","volume":"8","author":"D Goswami","year":"2021","unstructured":"Goswami, D. et al. Design considerations for macroencapsulation devices for stem cell derived islets for the treatment of type 1 diabetes. Adv. Sci. 8, 2100820 (2021).","journal-title":"Adv. Sci."},{"key":"1145_CR18","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1097\/01.tp.0000203858.41105.88","volume":"81","author":"A Pileggi","year":"2006","unstructured":"Pileggi, A. et al. Reversal of diabetes by pancreatic islet transplantation into a subcutaneous, neovascularized device. Transplantation 81, 1318\u20131324 (2006).","journal-title":"Transplantation"},{"key":"1145_CR19","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/TP.0b013e31817efc78","volume":"86","author":"AK S\u00f6renby","year":"2008","unstructured":"S\u00f6renby, A. K. et al. Preimplantation of an immunoprotective device can lower the curative dose of islets to that of free islet transplantation\u2014studies in a rodent model. Transplantation 86, 364\u2013366 (2008).","journal-title":"Transplantation"},{"key":"1145_CR20","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3727\/000000005783982792","volume":"14","author":"CR Halberstadt","year":"2005","unstructured":"Halberstadt, C. R. et al. Subcutaneous transplantation of islets into streptozocin-induced diabetic rats. Cell Transplant. 14, 595\u2013605 (2005).","journal-title":"Cell Transplant."},{"key":"1145_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.biomaterials.2017.03.032","volume":"131","author":"R Mahou","year":"2017","unstructured":"Mahou, R., Zhang, D. K. Y., Vlahos, A. E. & Sefton, M. V. Injectable and inherently vascularizing semi-interpenetrating polymer network for delivering cells to the subcutaneous space. Biomaterials 131, 27\u201335 (2017).","journal-title":"Biomaterials"},{"key":"1145_CR22","doi-asserted-by":"publisher","first-page":"e1900667","DOI":"10.1002\/adhm.201900667","volume":"8","author":"VF Coindre","year":"2019","unstructured":"Coindre, V. F., Carleton, M. M. & Sefton, M. V. Methacrylic acid copolymer coating enhances constructive remodeling of polypropylene mesh by increasing the vascular response. Adv. Healthc. Mater. 8, e1900667 (2019).","journal-title":"Adv. Healthc. Mater."},{"key":"1145_CR23","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1177\/096368970000900523","volume":"9","author":"Y Kawakami","year":"2000","unstructured":"Kawakami, Y. et al. Modified subcutaneous tissue with neovascularization is useful as the site for pancreatic islet transplantation. Cell Transplant. 9, 729\u2013732 (2000).","journal-title":"Cell Transplant."},{"key":"1145_CR24","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3727\/000000001783986693","volume":"10","author":"Y Gu","year":"2001","unstructured":"Gu, Y. et al. Development of a new method to induce angiogenesis at subcutaneous site of streptozotocin-induced diabetic rats for islet transplantation. Cell Transplant. 10, 453\u2013457 (2001).","journal-title":"Cell Transplant."},{"key":"1145_CR25","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/00007890-200201150-00023","volume":"73","author":"W Wang","year":"2002","unstructured":"Wang, W. et al. Reversal of diabetes in mice by xenotransplantation of a bioartificial pancreas in a prevascularized subcutaneous site. Transplantation 73, 122\u2013129 (2002).","journal-title":"Transplantation"},{"key":"1145_CR26","doi-asserted-by":"publisher","first-page":"e1700184","DOI":"10.1126\/sciadv.1700184","volume":"3","author":"JD Weaver","year":"2017","unstructured":"Weaver, J. D. et al. Vasculogenic hydrogel enhances islet survival, engraftment, and function in leading extrahepatic sites. Sci. Adv. 3, e1700184 (2017).","journal-title":"Sci. Adv."},{"key":"1145_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12373-5","volume":"10","author":"W Song","year":"2019","unstructured":"Song, W. et al. Engineering transferrable microvascular meshes for subcutaneous islet transplantation. Nat. Commun. 10, 4602 (2019).","journal-title":"Nat. Commun."},{"key":"1145_CR28","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1016\/j.stem.2021.08.001","volume":"28","author":"Y Aghazadeh","year":"2021","unstructured":"Aghazadeh, Y. et al. Microvessels support engraftment and functionality of human islets and hESC-derived pancreatic progenitors in diabetes models. Cell Stem Cell 28, 1936\u20131949.e8 (2021).","journal-title":"Cell Stem Cell"},{"key":"1145_CR29","doi-asserted-by":"publisher","first-page":"e112","DOI":"10.1097\/TP.0000000000001663","volume":"101","author":"AM Smink","year":"2017","unstructured":"Smink, A. M. et al. The efficacy of a prevascularized, retrievable poly (d, l,-lactide-co-\u03b5-caprolactone) subcutaneous scaffold as transplantation site for pancreatic islets. Transplantation 101, e112\u2013e119 (2017).","journal-title":"Transplantation"},{"key":"1145_CR30","doi-asserted-by":"publisher","first-page":"e650","DOI":"10.1152\/ajpendo.00073.2018","volume":"315","author":"CH Stephens","year":"2018","unstructured":"Stephens, C. H. et al. In situ type I oligomeric collagen macroencapsulation promotes islet longevity and function in vitro and in vivo. Am. J. Physiol. Endocrinol. Metab. 315, e650\u2013e661 (2018).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"1145_CR31","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s42255-020-0269-7","volume":"2","author":"M Yu","year":"2020","unstructured":"Yu, M. et al. Islet transplantation in the subcutaneous space achieves long-term euglycaemia in preclinical models of type 1 diabetes. Nat. Metab. 2, 1013\u20131020 (2020).","journal-title":"Nat. Metab."},{"key":"1145_CR32","doi-asserted-by":"publisher","first-page":"e12581","DOI":"10.1111\/xen.12581","volume":"27","author":"P Kuppan","year":"2020","unstructured":"Kuppan, P. et al. Co\u2010transplantation of human adipose\u2010derived mesenchymal stem cells with neonatal porcine islets within a prevascularized subcutaneous space augments the xenograft function. Xenotransplantation 27, e12581 (2020).","journal-title":"Xenotransplantation"},{"key":"1145_CR33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.5500\/wjt.v6.i1.69","volume":"6","author":"U Barkai","year":"2016","unstructured":"Barkai, U., Rotem, A. & de Vos, P. Survival of encapsulated islets: more than a membrane story. World J. Transplant. 6, 69\u201390 (2016).","journal-title":"World J. Transplant."},{"key":"1145_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2019.04.017","volume":"210","author":"MM Coronel","year":"2019","unstructured":"Coronel, M. M., Liang, J.-P., Li, Y. & Stabler, C. Oxygen generating biomaterial improves the function and efficacy of beta cells within a macroencapsulation device. Biomaterials 210, 1\u201311 (2019).","journal-title":"Biomaterials"},{"key":"1145_CR35","doi-asserted-by":"publisher","first-page":"eabd5835","DOI":"10.1126\/sciadv.abd5835","volume":"7","author":"L-H Wang","year":"2021","unstructured":"Wang, L.-H. et al. An inverse-breathing encapsulation system for cell delivery. Sci. Adv. 7, eabd5835 (2021).","journal-title":"Sci. Adv."},{"key":"1145_CR36","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1111\/ajt.14642","volume":"18","author":"P-O Carlsson","year":"2018","unstructured":"Carlsson, P.-O. et al. Transplantation of macroencapsulated human islets within the bioartificial pancreas \u03b2Air to patients with type 1 diabetes mellitus. Am. J. Transplant. 18, 1735\u20131744 (2018).","journal-title":"Am. J. Transplant."},{"key":"1145_CR37","doi-asserted-by":"publisher","first-page":"11745","DOI":"10.1073\/pnas.1708420114","volume":"114","author":"B Ludwig","year":"2017","unstructured":"Ludwig, B. et al. Favorable outcome of experimental islet xenotransplantation without immunosuppression in a nonhuman primate model of diabetes. Proc. Natl Acad. Sci. USA 114, 11745\u201311750 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1145_CR38","doi-asserted-by":"publisher","first-page":"19054","DOI":"10.1073\/pnas.1317561110","volume":"110","author":"B Ludwig","year":"2013","unstructured":"Ludwig, B. et al. Transplantation of human islets without immunosuppression. Proc. Natl Acad. Sci. USA 110, 19054\u201319058 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1145_CR39","doi-asserted-by":"publisher","first-page":"e70150","DOI":"10.1371\/journal.pone.0070150","volume":"8","author":"T Neufeld","year":"2013","unstructured":"Neufeld, T. et al. The efficacy of an immunoisolating membrane system for islet xenotransplantation in minipigs. PLoS ONE 8, e70150 (2013).","journal-title":"PLoS ONE"},{"key":"1145_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-23862-w","volume":"8","author":"Y Evron","year":"2018","unstructured":"Evron, Y. et al. Long-term viability and function of transplanted islets macroencapsulated at high density are achieved by enhanced oxygen supply. Sci. Rep. 8, 6508 (2018).","journal-title":"Sci. Rep."},{"key":"1145_CR41","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.2337\/db13-1649","volume":"63","author":"DR Burnett","year":"2014","unstructured":"Burnett, D. R. et al. Glucose sensing in the peritoneal space offers faster kinetics than sensing in the subcutaneous space. Diabetes 63, 2498\u20132505 (2014).","journal-title":"Diabetes"},{"key":"1145_CR42","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nbt.3211","volume":"33","author":"AR Pepper","year":"2015","unstructured":"Pepper, A. R. et al. A prevascularized subcutaneous device-less site for islet and cellular transplantation. Nat. Biotechnol. 33, 518\u2013523 (2015).","journal-title":"Nat. Biotechnol."},{"key":"1145_CR43","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1073\/pnas.1708806115","volume":"115","author":"D An","year":"2018","unstructured":"An, D. et al. Designing a retrievable and scalable cell encapsulation device for potential treatment of type 1 diabetes. Proc. Natl Acad. Sci. USA 115, e263\u2013e272 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1145_CR44","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.3390\/cancers14092178","volume":"14","author":"RM Morris","year":"2022","unstructured":"Morris, R. M., Mortimer, T. O. & O\u2019Neill, K. L. Cytokines: can cancer get the message? Cancers 14, 2178 (2022).","journal-title":"Cancers"},{"key":"1145_CR45","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/s12276-020-00500-y","volume":"52","author":"WS Lee","year":"2020","unstructured":"Lee, W. S., Yang, H., Chon, H. J. & Kim, C. Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity. Exp. Mol. Med. 52, 1475\u20131485 (2020).","journal-title":"Exp. Mol. Med."},{"key":"1145_CR46","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.3389\/fimmu.2019.01426","volume":"10","author":"E Fahey","year":"2019","unstructured":"Fahey, E. & Doyle, S. L. IL-1 family cytokine regulation of vascular permeability and angiogenesis. Front. Immunol. 10, 1426 (2019).","journal-title":"Front. Immunol."},{"key":"1145_CR47","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/sj.jcbfm.9600509","volume":"28","author":"Y Fan","year":"2008","unstructured":"Fan, Y. et al. Interleukin-6 stimulates circulating blood-derived endothelial progenitor cell angiogenesis in vitro. J. Cereb. Blood Flow Metab. 28, 90\u201398 (2008).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"1145_CR48","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/cvr\/cvu062","volume":"102","author":"S Van Linthout","year":"2014","unstructured":"Van Linthout, S., Miteva, K. & Tsch\u00f6pe, C. Crosstalk between fibroblasts and inflammatory cells. Cardiovasc. Res. 102, 258\u2013269 (2014).","journal-title":"Cardiovasc. Res."},{"key":"1145_CR49","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/sj.jid.5700786","volume":"127","author":"S Werner","year":"2007","unstructured":"Werner, S., Krieg, T. & Smola, H. Keratinocyte\u2013fibroblast interactions in wound healing. J. Invest. Dermatol. 127, 998\u20131008 (2007).","journal-title":"J. Invest. Dermatol."},{"key":"1145_CR50","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/(SICI)1097-4636(199801)39:1<61::AID-JBM8>3.0.CO;2-G","volume":"39","author":"M Bri\u0161\u0161ov\u00e1","year":"1998","unstructured":"Bri\u0161\u0161ov\u00e1, M. et al. Control and measurement of permeability for design of microcapsule cell delivery system. J. Biomed. Mater. Res. 39, 61\u201370 (1998).","journal-title":"J. Biomed. Mater. Res."},{"key":"1145_CR51","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1006\/abio.1996.0435","volume":"242","author":"M Bri\u0161\u0161ov\u00e1","year":"1996","unstructured":"Bri\u0161\u0161ov\u00e1, M. et al. Evaluation of microcapsule permeability via inverse size exclusion chromatography. Anal. Biochem. 242, 104\u2013111 (1996).","journal-title":"Anal. Biochem."},{"key":"1145_CR52","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/jbm.b.32667","volume":"100","author":"CA Hoesli","year":"2012","unstructured":"Hoesli, C. A. et al. Reversal of diabetes by \u03b2TC3 cells encapsulated in alginate beads generated by emulsion and internal gelation. J. Biomed. Mater. Res. B 100, 1017\u20131028 (2012).","journal-title":"J. Biomed. Mater. Res. B"},{"key":"1145_CR53","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/j.1399-3089.2009.00548.x","volume":"16","author":"AR Pepper","year":"2009","unstructured":"Pepper, A. R. et al. Diabetic rats and mice are resistant to porcine and human insulin: flawed experimental models for testing islet xenografts. Xenotransplantation 16, 502\u2013510 (2009).","journal-title":"Xenotransplantation"},{"key":"1145_CR54","doi-asserted-by":"publisher","first-page":"e0183780","DOI":"10.1371\/journal.pone.0183780","volume":"12","author":"H Komatsu","year":"2017","unstructured":"Komatsu, H. et al. Oxygen environment and islet size are the primary limiting factors of isolated pancreatic islet survival. PLoS ONE 12, e0183780 (2017).","journal-title":"PLoS ONE"},{"key":"1145_CR55","doi-asserted-by":"publisher","first-page":"533\u2013543","DOI":"10.1097\/MPA.0000000000001050","volume":"47","author":"H Komatsu","year":"2018","unstructured":"Komatsu, H., Kandeel, F. & Mullen, Y. Impact of oxygen on pancreatic islet survival. Pancreas 47, 533\u2013543 (2018).","journal-title":"Pancreas"},{"key":"1145_CR56","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41587-022-01246-w","volume":"40","author":"E Dolgin","year":"2022","unstructured":"Dolgin, E. Diabetes cell therapies take evasive action. Nat. Biotechnol. 40, 291\u2013295 (2022).","journal-title":"Nat. Biotechnol."},{"key":"1145_CR57","first-page":"e2132","volume":"4","author":"BL Gala-Lopez","year":"2016","unstructured":"Gala-Lopez, B. L. et al. Subcutaneous clinical islet transplantation in a prevascularized subcutaneous pouch-preliminary experience. CellR4 4, e2132 (2016).","journal-title":"CellR4"},{"key":"1145_CR58","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1097\/01.tp.0000804420.88438.67","volume":"105","author":"P Bachul","year":"2021","unstructured":"Bachul, P. et al. 307.5: modified approach allowed for improved islet allotransplantation into pre-vascularized Sernova Cell Pouch device-preliminary results of the phase I\/II clinical trial at University of Chicago. Transplantation 105, S25 (2021).","journal-title":"Transplantation"},{"key":"1145_CR59","first-page":"e2251","volume":"5","author":"CK Colton","year":"2017","unstructured":"Colton, C. K. & Weir, G. Commentary-a hard lesson about transplanting islets into prevascularized devices. CellR4 5, e2251 (2017).","journal-title":"CellR4"},{"key":"1145_CR60","doi-asserted-by":"publisher","first-page":"2007483","DOI":"10.1002\/adfm.202007483","volume":"31","author":"L Yang","year":"2021","unstructured":"Yang, L. et al. Regenerating hair in prevascularized tissue space formed by a controllable foreign body reaction. Adv. Funct. Mater. 31, 2007483 (2021).","journal-title":"Adv. Funct. Mater."},{"key":"1145_CR61","doi-asserted-by":"publisher","first-page":"886","DOI":"10.2337\/diab.41.7.886","volume":"41","author":"RP Lanza","year":"1992","unstructured":"Lanza, R. P. et al. Treatment of severely diabetic pancreatectomized dogs using a diffusion-based hybrid pancreas. Diabetes 41, 886\u2013889 (1992).","journal-title":"Diabetes"},{"key":"1145_CR62","first-page":"669","volume":"24","author":"RP Lanza","year":"1992","unstructured":"Lanza, R. P. et al. Successful xenotransplantation of a diffusion-based biohybrid artificial pancreas: a study using canine, bovine, and porcine islets. Transplant. Proc. 24, 669\u2013671 (1992).","journal-title":"Transplant. Proc."},{"key":"1145_CR63","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.2337\/diab.41.12.1503","volume":"41","author":"RP Lanza","year":"1992","unstructured":"Lanza, R. P., Sullivan, S. J. & Chick, W. L. Islet transplantation with immunoisolation. Diabetes 41, 1503\u20131510 (1992).","journal-title":"Diabetes"},{"key":"1145_CR64","doi-asserted-by":"crossref","unstructured":"Lanza, R. P. et al. Pancreatic islet transplantation using membrane diffusion chambers. Tranplant. Proc. 24, 2935\u20132936 (1992).","DOI":"10.1016\/S0031-3025(16)35918-9"},{"key":"1145_CR65","doi-asserted-by":"publisher","first-page":"11100","DOI":"10.1073\/pnas.88.24.11100","volume":"88","author":"RP Lanza","year":"1991","unstructured":"Lanza, R. P. et al. Xenotransplantation of canine, bovine, and porcine islets in diabetic rats without immunosuppression. Proc. Natl Acad. Sci. USA 88, 11100\u201311104 (1991).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1145_CR66","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s41551-018-0275-1","volume":"2","author":"MA Bochenek","year":"2018","unstructured":"Bochenek, M. A. et al. Alginate encapsulation as long-term immune protection of allogeneic pancreatic islet cells transplanted into the omental bursa of macaques. Nat. Biomed. Eng. 2, 810\u2013821 (2018).","journal-title":"Nat. Biomed. Eng."},{"key":"1145_CR67","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nbt.3462","volume":"34","author":"AJ Vegas","year":"2016","unstructured":"Vegas, A. J. et al. Combinatorial hydrogel library enables identification of materials that mitigate the foreign body response in primates. Nat. Biotechnol. 34, 345\u2013352 (2016).","journal-title":"Nat. Biotechnol."},{"key":"1145_CR68","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1097\/TP.0b013e3181f6e267","volume":"90","author":"D Dufrane","year":"2010","unstructured":"Dufrane, D., Goebbels, R.-M. & Gianello, P. Alginate macroencapsulation of pig islets allows correction of streptozotocin-induced diabetes in primates up to 6 months without immunosuppression.Transplantation 90, 1054\u20131062 (2010).","journal-title":"Transplantation"},{"key":"1145_CR69","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1016\/j.biomaterials.2006.01.028","volume":"27","author":"D Dufrane","year":"2006","unstructured":"Dufrane, D. et al. The influence of implantation site on the biocompatibility and survival of alginate encapsulated pig islets in rats. Biomaterials 27, 3201\u20133208 (2006).","journal-title":"Biomaterials"},{"key":"1145_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13238-7","volume":"10","author":"Q Liu","year":"2019","unstructured":"Liu, Q. et al. Zwitterionically modified alginates mitigate cellular overgrowth for cell encapsulation. Nat. Commun. 10, 5262 (2019).","journal-title":"Nat. Commun."},{"key":"1145_CR71","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/S0142-9612(00)00201-5","volume":"22","author":"CK Kuo","year":"2001","unstructured":"Kuo, C. K. & Ma, P. X. Ionically crosslinked alginate hydrogels as scaffolds for tissue engineering: part 1. Structure, gelation rate and mechanical properties. Biomaterials 22, 511\u2013521 (2001).","journal-title":"Biomaterials"},{"key":"1145_CR72","doi-asserted-by":"publisher","first-page":"2010169","DOI":"10.1002\/adfm.202010169","volume":"31","author":"TT Pham","year":"2021","unstructured":"Pham, T. T. et al. Hydrogel coatings: surface\u2010triggered in situ gelation for tunable conformal hydrogel coating of therapeutic cells and biomedical devices. Adv. Funct. Mater. 31, 2010169 (2021).","journal-title":"Adv. Funct. Mater."},{"key":"1145_CR73","doi-asserted-by":"publisher","first-page":"322","DOI":"10.2174\/1573399812666160427104157","volume":"13","author":"G Fousteri","year":"2017","unstructured":"Fousteri, G., Ippolito, E., Ahmed, R. & Hamad, A. R. A. Beta-cell specific autoantibodies: are they just an indicator of type 1 diabetes?. Curr. Diabetes Rev. 13, 322\u2013329 (2017).","journal-title":"Curr. Diabetes Rev."},{"key":"1145_CR74","doi-asserted-by":"publisher","first-page":"eabb4601","DOI":"10.1126\/scitranslmed.abb4601","volume":"13","author":"X Wang","year":"2021","unstructured":"Wang, X. et al. A nanofibrous encapsulation device for safe delivery of insulin-producing cells to treat type 1 diabetes. Sci. Transl. Med. 13, eabb4601 (2021).","journal-title":"Sci. Transl. Med."},{"key":"1145_CR75","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.pacs.2015.09.001","volume":"3","author":"MKA Singh","year":"2015","unstructured":"Singh, M. K. A. & Steenbergen, W. Photoacoustic-guided focused ultrasound (PAFUSion) for identifying reflection artifacts in photoacoustic imaging. Photoacoustics 3, 123\u2013131 (2015).","journal-title":"Photoacoustics"},{"key":"1145_CR76","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/nrendo.2016.178","volume":"13","author":"AMJ Shapiro","year":"2017","unstructured":"Shapiro, A. M. J., Pokrywczynska, M. & Ricordi, C. Clinical pancreatic islet transplantation. Nat. Rev. Endocrinol. 13, 268\u2013277 (2017).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1145_CR77","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1749-6632.1999.tb08497.x","volume":"875","author":"H Wu","year":"1999","unstructured":"Wu, H. et al. In situ electrochemical oxygen generation with an immunoisolation device. Ann. N. Y. Acad. Sci. 875, 105\u2013125 (1999).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"1145_CR78","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1742-4682-8-20","volume":"8","author":"P Buchwald","year":"2011","unstructured":"Buchwald, P. A local glucose-and oxygen concentration-based insulin secretion model for pancreatic islets. Theor. Biol. Med. Model. 8, 20 (2011).","journal-title":"Theor. Biol. Med. Model."},{"key":"1145_CR79","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1742-4682-6-5","volume":"6","author":"P Buchwald","year":"2009","unstructured":"Buchwald, P. FEM-based oxygen consumption and cell viability models for avascular pancreatic islets. Theor. Biol. Med. Model. 6, 5 (2009).","journal-title":"Theor. Biol. Med. Model."},{"key":"1145_CR80","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/bit.26442","volume":"115","author":"P Buchwald","year":"2018","unstructured":"Buchwald, P. et al. Glucose\u2010stimulated insulin release: parallel perifusion studies of free and hydrogel encapsulated human pancreatic islets. Biotechnol. Bioeng. 115, 232\u2013245 (2018).","journal-title":"Biotechnol. Bioeng."},{"key":"1145_CR81","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3727\/096368909X476968","volume":"18","author":"P Buchwald","year":"2009","unstructured":"Buchwald, P. et al. Quantitative assessment of islet cell products: estimating the accuracy of the existing protocol and accounting for islet size distribution. Cell Transplant. 18, 1223\u20131235 (2009).","journal-title":"Cell Transplant."},{"key":"1145_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33760-5","volume":"13","author":"AU Ernst","year":"2022","unstructured":"Ernst, A. U. et al. A predictive computational platform for optimizing the design of bioartificial pancreas devices. Nat. Commun. 13, 6031 (2022).","journal-title":"Nat. Commun."},{"key":"1145_CR83","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1210\/en.2015-1562","volume":"157","author":"J Lyon","year":"2016","unstructured":"Lyon, J. et al. Research-focused isolation of human islets from donors with and without diabetes at the Alberta Diabetes Institute IsletCore. Endocrinology 157, 560\u2013569 (2016).","journal-title":"Endocrinology"},{"key":"1145_CR84","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.jmbbm.2014.05.020","volume":"37","author":"SV Bhujbal","year":"2014","unstructured":"Bhujbal, S. V., Paredes-Juarez, G. A., Niclou, S. P. & de Vos, P. Factors influencing the mechanical stability of alginate beads applicable for immunoisolation of mammalian cells. J. Mech. Behav. Biomed. Mater. 37, 196\u2013208 (2014).","journal-title":"J. Mech. Behav. Biomed. Mater."}],"container-title":["Nature Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41551-023-01145-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-023-01145-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-023-01145-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T14:02:52Z","timestamp":1729087372000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41551-023-01145-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,5]]},"references-count":84,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["1145"],"URL":"https:\/\/doi.org\/10.1038\/s41551-023-01145-8","relation":{},"ISSN":["2157-846X"],"issn-type":[{"value":"2157-846X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,5]]},"assertion":[{"value":"16 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.M.J.S. serves as a consultant to ViaCyte Inc., Vertex Inc., Hemostemix Inc. and Aspect Biosystems Ltd. B.E. discloses financial interests in O2M. A.M.J.S. holds patents (US10434122B2 and CA2865122A1) for the \u2018device-less\u2019 prevascularization technique described in this paper. J.A.F. and M.M. are inventors on a patent application (US10493107B2) that covers the cell-encapsulation device described in this paper and are co-founders of Persista Bio. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}